A critical look at pharma coverage

Today is FiercePharma second edition of Industry Voices. As previously announced, we're bringing you a variety of outside columnists to discuss issues affecting the pharmaceutical industry and examine the trends that are changing the way drugmakers do business.

Our second columnist is Robert Goldberg, a blogger with DrugWonks. DrugWonks is the blog of the Centers for Medicine in the Public Interest (CMPI), which debates today's drug policies. Scroll down or click here to check out his thoughts on the future of the pharmaceutical industry and the media's coverage of drug safety issues. - Maureen

Suggested Articles

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.

With two more former Insys executives facing prison time, another is claiming sexist hiring as an excuse for her role in a kickback scheme.